Cowen Prime Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $617K | Sell |
38,400
-2,400
| -6% | -$39.6K | 0.21% | 53 |
|
|
2023
Q1 | $597K | Hold |
40,800
| – | – | 0.24% | 54 |
|
|
2022
Q4 | $377K | Buy |
40,800
+14,800
| +57% | +$138K | 0.16% | 63 |
|
|
2022
Q3 | $224K | Hold |
26,000
| – | – | 0.13% | 69 |
|
|
2022
Q2 | $212K | Sell |
26,000
-157,500
| -86% | -$1.5M | 0.12% | 74 |
|
|
2022
Q1 | $2.23M | Buy |
183,500
+157,000
| +592% | +$3.3M | 0.94% | 26 |
|
|
2021
Q4 | $904K | Hold |
26,500
| – | – | 0.31% | 52 |
|
|
2021
Q3 | $1.28M | Hold |
26,500
| – | – | 0.48% | 43 |
|
|
2021
Q2 | $1.2M | Hold |
26,500
| – | – | 0.43% | 45 |
|
|
2021
Q1 | $1.28M | Buy |
26,500
+1,200
| +5% | +$62.5K | 0.48% | 47 |
|
|
2020
Q4 | $1.36M | Sell |
25,300
-8,976
| -26% | -$406K | 0.6% | 35 |
|
|
2020
Q3 | $1.26M | Buy |
34,276
+8,276
| +32% | +$308K | 0.62% | 32 |
|
|
2020
Q2 | $212K | Sell |
26,000
-45,576
| -64% | -$1.26M | 0.12% | 74 |
|
|
2020
Q1 | $1.98M | Sell |
71,576
-258,020
| -78% | -$7.73M | 1.21% | 20 |
|
|
2019
Q4 | $9.64M | Sell |
329,596
-42,720
| -11% | -$1.02M | 4.41% | 6 |
|
|
2019
Q3 | $7.12M | Sell |
372,316
-28,600
| -7% | -$671K | 3.68% | 8 |
|
|
2019
Q2 | $8.8M | Sell |
400,916
-183,850
| -31% | -$4.03M | 4.25% | 7 |
|
|
2019
Q1 | $12M | Sell |
584,766
-82,454
| -12% | -$1.43M | 6.2% | 4 |
|
|
2018
Q4 | $8.41M | Sell |
667,220
-73,976
| -10% | -$1.1M | 5.07% | 4 |
|
|
2018
Q3 | $11.4M | Sell |
741,196
-71,609
| -9% | -$990K | 5.29% | 3 |
|
|
2018
Q2 | $10.7M | Sell |
812,805
-331,231
| -29% | -$3.65M | 5.25% | 4 |
|
|
2018
Q1 | $9.34M | Buy |
1,144,036
+3,447
| +0.3% | +$27.9K | 5.18% | 3 |
|
|
2017
Q4 | $10.1M | Buy |
1,140,589
+71,215
| +7% | +$657K | 4.92% | 4 |
|
|
2017
Q3 | $11.9M | Sell |
1,069,374
-239,352
| -18% | -$2.33M | 5.66% | 3 |
|
|
2017
Q2 | $11.7M | Buy |
1,308,726
+120,250
| +10% | +$954K | 5.4% | 3 |
|
|
2017
Q1 | $9.38M | Buy |
1,188,476
+225,550
| +23% | +$1.84M | 4.82% | 3 |
|
|
2016
Q4 | $8.25M | Sell |
962,926
-18,100
| -2% | -$155K | 4.45% | 3 |
|
|
2016
Q3 | $8.06M | Sell |
981,026
-37,100
| -4% | -$311K | 3.66% | 4 |
|
|
2016
Q2 | $8.19M | Sell |
1,018,126
-463,500
| -31% | -$3.72M | 3.98% | 5 |
|
|
2016
Q1 | $9.99M | Buy |
1,481,626
+303,700
| +26% | +$2M | 4.63% | 4 |
|
|
2015
Q4 | $9.27M | Sell |
1,177,926
-25,000
| -2% | -$183K | 4.09% | 6 |
|
|
2015
Q3 | $6.89M | Sell |
1,202,926
-42,300
| -3% | -$262K | 3.22% | 7 |
|
|
2015
Q2 | $6.74M | Buy |
1,245,226
+507,226
| +69% | +$2.62M | 2.64% | 9 |
|
|
2015
Q1 | $3.45M | Buy |
738,000
+669,000
| +970% | +$2.91M | 1.42% | 19 |
|
|
2014
Q4 | $288K | Buy |
+69,000
| New | +$317K | 0.11% | 93 |
|
Other funds holding NEO
GF
FLAM
Cowen Prime Advisors's NEO Position: Q2 2023 in Review
Cowen Prime Advisors reduced its NeoGenomics (NEO) stake by 5.9% in Q2 2023, selling an estimated $39.6K and leaving 38,400 shares worth $617K. The position accounts for 0.21% of the portfolio, ranked #53.
Cowen Prime Advisors first reported a position in NEO in Q4 2014 and has held it in 35 quarters since. The position peaked at $12M in Q1 2019. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2023.
- Cowen Prime Advisors held 38,400 shares of NeoGenomics worth $617K as of Q2 2023.
- Cowen Prime Advisors sold 2,400 NeoGenomics shares in Q2 2023, an estimated $39.6K.
- NeoGenomics made up 0.21% of Cowen Prime Advisors's portfolio in Q2 2023, its #53 holding.
- Cowen Prime Advisors first reported a position in NeoGenomics in Q4 2014 and has held it in 35 quarters since.
- Cowen Prime Advisors's NeoGenomics position peaked at $12M in Q1 2019.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.